Insiders · CMPX

Jonathan Anderman

General Counsel at Compass Therapeutics, Inc. (CMPX) since August 2024

Jonathan Anderman has filed 7 insider reports with the SEC since August 2024, as general Counsel at Compass Therapeutics, Inc. (CMPX). Jonathan Anderman made no open-market purchases or sales in the last 12 months. In the latest amended filing, on April 30, 2026, Jonathan Anderman bought 25,000 shares of Compass Therapeutics, Inc. (CMPX) for $47.3K at an average of $1.89.

Filings
7
Companies
1
Bought on market
$30.8K
Sold on market
None

Companies where Jonathan Anderman is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Compass Therapeutics, Inc. logo
CMPX
Compass Therapeutics, Inc.
General Counselsince August 2024196,000$30.8K$1.54$0.6882-55%Apr 30, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Jonathan Anderman with

Other insiders at the same companies

Questions about Jonathan Anderman

What is Jonathan Anderman's role at Compass Therapeutics, Inc.?
Jonathan Anderman reports to the SEC as general Counsel at Compass Therapeutics, Inc. (CMPX), according to the latest filing on April 30, 2026.
How many shares does Jonathan Anderman own?
After the latest filing that states it, Jonathan Anderman directly owned 196,000 shares of Compass Therapeutics, Inc. (CMPX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jonathan Anderman bought or sold stock recently?
The most recent open-market purchase was on April 7, 2025: bought 20,000 shares of Compass Therapeutics, Inc. (CMPX) for $30.8K at an average of $1.54.
How do I get alerts when Jonathan Anderman files?
Follow Jonathan Anderman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan Anderman (SEC CIK 0002032625). Totals count each trade once, skipping amendments whose original is on file, from Aug 9, 2024 on. View on SEC EDGAR · Get this as JSON